Related Experiment Video
Updated: Dec 20, 2025

Measurement of Fatty Acid β-Oxidation in a Suspension of Freshly Isolated Mouse Hepatocytes
Published on: September 9, 2021
Effect of temperature on 3,4-Methylenedioxypyrovalerone (MDPV)-induced metabolome disruption in primary mouse hepatic
Ana Margarida Araújo1, Maria de Lourdes Bastos1, Félix Carvalho1
1UCIBIO, REQUIMTE, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313, Porto, Portugal.
Abstract:
3,4-Methylenedioxypyrovalerone (MDPV) is one of the most popular cathinone derivatives worldwide and has recently been associated with several intoxications and deaths, in which, similarly to amphetamines, hyperthermia appears to play a prominent role. However, there remains a huge information gap underlying the mechanisms associated with its hepatotoxicity, namely under hyperthermic conditions. Here, we use a sensitive untargeted metabolomic approach based on gas chromatography-mass spectrometry (GC-MS) to investigate the effect of subtoxic and toxic concentrations of MDPV on the metabolic profile of primary mouse hepatocytes (PMH), under normothermic and hyperthermic conditions. For this purpose, hepatocytes were exposed to increasing concentrations of MDPV (LC01, LC10 and LC30) for 24 h, at 37 °C or 40.5 °C, and alterations on both intracellular metabolome and extracellular volatilome were evaluated. Multivariate analysis showed a clear separation between MDPV exposed cells and control cells in normothermic conditions, even at subtoxic concentrations (LC01 and LC10). In normothermia, there was a significant dysregulation of pathways associated with ascorbate metabolism, tricarboxylic acid (TCA) cycle and pyruvate metabolism. These metabolic changes were significantly increased at 40.5 °C, and several other pathways appear to be affected with the evolution of toxicity caused by MDPV under hyperthermic conditions, namely aspartate and glutamate metabolism, phenylalanine and tyrosine biosynthesis, aminoacyl-tRNA biosynthesis, butanoate metabolism, among others. Overall, our findings provide novel insights into the mechanism of hepatotoxicity triggered by MDPV and highlight the higher risks that may occur under hyperthermic conditions.
Insights
3,4-Methylenedioxypyrovalerone (MDPV) causes liver damage, especially under high temperatures. This study used metabolomics to reveal how MDPV disrupts cellular metabolism in mouse liver cells, highlighting increased risks during hyperthermia.
Area of Science:
- Toxicology
- Metabolomics
- Hepatology
Background:
- 3,4-Methylenedioxypyrovalerone (MDPV) is a widely used cathinone derivative linked to intoxications and fatalities.
- Hyperthermia is implicated in MDPV-related deaths, but its role in MDPV-induced hepatotoxicity is poorly understood.
Purpose of the Study:
- To investigate the metabolic effects of MDPV on primary mouse hepatocytes (PMH) under normothermic and hyperthermic conditions.
- To elucidate the mechanisms of MDPV hepatotoxicity, particularly under elevated temperatures.
Main Methods:
- Utilized a gas chromatography-mass spectrometry (GC-MS) based untargeted metabolomic approach.
- Exposed PMH to varying concentrations of MDPV (LC01, LC10, LC30) at 37°C and 40.5°C for 24 hours.
- Evaluated intracellular metabolome and extracellular volatilome alterations.
Main Results:
- Multivariate analysis revealed distinct metabolic profiles for MDPV-exposed cells versus controls, even at subtoxic concentrations.
- Normothermia showed dysregulation in ascorbate metabolism, TCA cycle, and pyruvate metabolism.
- Hyperthermia (40.5°C) exacerbated these changes and affected additional pathways including aspartate/glutamate metabolism and aminoacyl-tRNA biosynthesis.
Conclusions:
- MDPV exposure significantly alters cellular metabolism in primary mouse hepatocytes.
- Hyperthermia intensifies MDPV-induced metabolic disruption, suggesting heightened hepatotoxicity risks under feverish conditions.
- Findings offer new insights into MDPV hepatotoxicity mechanisms, emphasizing the critical role of temperature.
Related Concept Videos
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs
The drug's acidity or basicity is essential in...
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
Drug Metabolism: Phase I Reactions
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

